Highlights
- Second quarter 2026 net sales rose 0.5% to $1,692.3 million, while organic net sales declined 0.4%.
- GAAP net income was $38.1 million, or $0.06 per diluted share, versus $64.7 million, or $0.09, a year earlier.
- Non-GAAP Adjusted EBITDA was $254.3 million, a 15.0% margin, versus $279.8 million and 16.6% a year earlier.
- Liquidity totaled $1,686.6 million, and $425.0 million remained available under a $500.0 million share repurchase authorization.
Avantor, Inc. (NYSE:AVTR) shares were trading near their 52-week high at USD 17.25 on October 21, 2026, up 3.76%. The life sciences supplier repaid $102.5 million of euro term loans during the second quarter, repriced one of those loans on July 14, and reported second quarter results in a Form 10-Q filed July 29.
Based in Radnor, Pennsylvania, Avantor is a Delaware corporation that describes itself as a global manufacturer and distributor serving biopharmaceutical, healthcare, education and government, and advanced technologies and applied materials customers. Since January 1, 2026 it has reported two segments: Bioscience & Medtech Products, which includes its Fluid Handling, NuSil and Process Chemicals businesses, and VWR Distribution & Services, which covers lab consumables, controlled environment consumables, equipment and instrumentation, and specialty procurement. Its fiscal year ends December 31.
Flat Sales, Lower Margins and Higher Taxes
Net sales for the three months ended June 30, 2026 were $1,692.3 million, up from $1,683.4 million. Foreign currency added 0.9%, so organic net sales fell 0.4%. VWR Distribution & Services grew 2.7% to $1,240.5 million, or 1.7% organically, on higher controlled environment consumables and specialty procurement sales. Bioscience & Medtech Products fell 5.1% to $451.8 million, or 5.6% organically, on lower Fluid Handling and NuSil volumes.
Gross margin narrowed to 31.7% from 32.9%, which the company attributed to unfavorable product mix, inflation and lower volumes. Operating income was $121.8 million, versus $128.8 million, helped by the absence of last year's transformation costs. Income tax expense rose to $43.1 million from $17.0 million, taking net income down to $38.1 million from $64.7 million.
For six months, net sales were $3,273.7 million, up 0.3% with a 2.2% organic decline, and net income was $81.4 million, or $0.12 per diluted share.
Goodwill, Litigation and Other Risk Disclosures
The 10-Q gives prominent space to goodwill. Goodwill and other intangibles carried a combined $7,949.6 million at June 30, about 69% of total assets. The company recorded an $785.0 million non-cash goodwill impairment for its distribution unit in the third quarter of 2025. In the first quarter of 2026 it ran another interim test after a sustained decline in its share price and market capitalization, and found the VWR Distribution reporting unit's fair value exceeded carrying value by about 5.5%, so no charge was booked. It said a modest rise in discount rates or cut to cash flow forecasts could eliminate that cushion, and that a material non-cash impairment could be required in a future period.
The company and certain current and former officers and directors face consolidated securities class action and shareholder derivative suits in the U.S. District Court for the District of Delaware. The amended complaint alleges misleading statements about its competitive position, goodwill and operations, and defendants moved to dismiss on July 9, 2026. The company disputes the claims, and management does not believe a loss is probable.
Cash Flow, Debt and Capital Allocation
Operating activities provided $236.9 million of cash in six months, compared with $263.7 million, and non-GAAP free cash flow was $168.0 million versus $207.5 million. Cash and equivalents were $306.8 million, with $1,379.8 million of unused revolver availability. Total debt was $3,697.8 million, within its covenant limits. Required term loan payments are $30.8 million over the next 12 months.
On July 14, it repriced its euro term loan to a new B-7 tranche at EURIBOR plus 2.00%, down from 2.50%, keeping the $427.1 million balance and October 9, 2032 maturity. It made no share repurchases in the second quarter.
Outlook Items and Next Steps
The 10-Q contains no quantitative sales or earnings guidance. Management said available liquidity should meet its needs and that it is pursuing operational and strategic actions to improve VWR Distribution. After quarter end the company completed an internal reorganization that it estimates will produce a deferred tax benefit of about $142.0 million, to be recognized in the next interim period and subject to finalization. These are company estimates, and the results above cover the quarter ended June 30, 2026.






Please wait processing your request...